blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP0835127

EP0835127 - COMPOSITION CONTAINING A MYELIN-ASSOCIATED GLYCOPROTEIN (MAG) INHIBITOR WHICH COMPRISES AN ALTERED OR MUTATED FORM OF MAG [Right-click to bookmark this link]
Former [1998/16]COMPOSITIONS AND METHODS USING MYELIN-ASSOCIATED GLYCOPROTEIN (MAG) AND INHIBITORS THEREOF
[2003/44]
StatusNo opposition filed within time limit
Status updated on  15.07.2005
Database last updated on 20.03.2026
Most recent event   Tooltip25.07.2008Change - representativepublished on 27.08.2008  [2008/35]
Applicant(s)For all designated states
Research Foundation of Cuny, Hunter College
79 Fifth Avenue
New York, NY 10003 / US
[1998/16]
Inventor(s)01 / FILBIN, Marie, T.
Apt. 3D, 215 West 78 Street
New York, NY 10024 / US
[1998/16]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[N/P]
Former [2008/35]Vossius & Partner
Siebertstrasse 3
81675 München / DE
Former [1998/16]VOSSIUS & PARTNER
Siebertstrasse 4
81675 München / DE
Application number, filing date96923524.127.06.1996
[1998/16]
WO1996US11058
Priority number, dateUS19950000561P27.06.1995         Original published format: US 561 P
[1998/16]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9701352
Date:16.01.1997
Language:EN
[1997/04]
Type: A1 Application with search report 
No.:EP0835127
Date:15.04.1998
Language:EN
The application published by WIPO in one of the EPO official languages on 16.01.1997 takes the place of the publication of the European patent application.
[1998/16]
Type: B1 Patent specification 
No.:EP0835127
Date:08.09.2004
Language:EN
[2004/37]
Search report(s)International search report - published on:EP16.01.1997
ClassificationIPC:A61K38/17, A61K31/70, G01N33/68, // C07K14/705, C12N15/85, A61P25/00
[2003/44]
CPC:
A61K31/7016 (EP,US); A61K38/1709 (EP,US); A61P21/00 (EP);
A61P25/00 (EP); A61P25/14 (EP); A61P25/16 (EP);
A61P25/28 (EP); A61P43/00 (EP); A61P9/00 (EP);
C07K14/70503 (EP,US); C07K2319/00 (EP,US) (-)
Former IPC [1998/16]A61K38/17, A61K31/70, G01N33/68, // C07K14/705, C12N15/85
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1998/16]
TitleGerman:ZUSAMENZETZUNG ENTHALTEND EINEN INHIBITOR DES MYELIN ASSOZIIERTEN GLYCOPROTEINS (MAG), WELCHER EINER VERÄNDERTEN ODER MUTIERTEN FORM VON MAG ENTHÄLT[2003/44]
English:COMPOSITION CONTAINING A MYELIN-ASSOCIATED GLYCOPROTEIN (MAG) INHIBITOR WHICH COMPRISES AN ALTERED OR MUTATED FORM OF MAG[2003/44]
French:COMPOSITION COMPRENANT UN INHIBITEUR DE LA GLYCOPROTEINE ASSOCIEE A LA MYELINE (MAG) QUI CONTIENT UNE FORME MODIFIEE OU MUTEE DE MAG[2003/44]
Former [1998/16]ZUSAMMENSETZUNGEN UND VERFAHREN UNTER VERWENDUNG VON MYELIN-ANOZIERTE GLYCOPROTEINES (MAG) UND DEREN INHIBITOREN
Former [1998/16]COMPOSITIONS AND METHODS USING MYELIN-ASSOCIATED GLYCOPROTEIN (MAG) AND INHIBITORS THEREOF
Former [1998/16]COMPOSITIONS ET PROCEDES UTILISANT LA GLYCOPROTEINE ASSOCIEE A LA MYELINE (MAG) ET SES INHIBITEURS
Biological materialThis application mentions deposited biological material, check the file for details
Entry into regional phase26.01.1998National basic fee paid 
26.01.1998Designation fee(s) paid 
26.01.1998Examination fee paid 
Examination procedure24.01.1997Request for preliminary examination filed
International Preliminary Examining Authority: EP
26.01.1998Examination requested  [1998/16]
26.01.2001Despatch of a communication from the examining division (Time limit: M04)
05.06.2001Reply to a communication from the examining division
02.10.2001Despatch of a communication from the examining division (Time limit: M06)
06.03.2002Reply to a communication from the examining division
18.04.2002Despatch of a communication from the examining division (Time limit: M06)
28.10.2002Reply to a communication from the examining division
14.08.2003Despatch of a communication from the examining division (Time limit: M02)
08.09.2003Reply to a communication from the examining division
13.10.2003Communication of intention to grant the patent
22.04.2004Fee for grant paid
22.04.2004Fee for publishing/printing paid
Opposition(s)09.06.2005No opposition filed within time limit [2005/35]
Fees paidRenewal fee
29.06.1998Renewal fee patent year 03
29.06.1999Renewal fee patent year 04
28.06.2000Renewal fee patent year 05
29.06.2001Renewal fee patent year 06
01.07.2002Renewal fee patent year 07
30.06.2003Renewal fee patent year 08
30.06.2004Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipFI08.09.2004
IT08.09.2004
NL08.09.2004
DK08.12.2004
GR08.12.2004
SE08.12.2004
ES19.12.2004
PT08.02.2005
[2008/06]
Former [2006/14]FI08.09.2004
NL08.09.2004
DK08.12.2004
GR08.12.2004
SE08.12.2004
ES19.12.2004
Former [2005/46]FI08.09.2004
DK08.12.2004
GR08.12.2004
SE08.12.2004
ES19.12.2004
Former [2005/27]FI08.09.2004
GR08.12.2004
SE08.12.2004
ES19.12.2004
Former [2005/18]FI08.09.2004
GR08.12.2004
SE08.12.2004
Former [2005/11]FI08.09.2004
SE08.12.2004
Former [2005/10]SE08.12.2004
Cited inInternational search[X]   FILBIN M T ET AL: "MAG as an inhibitor of neurite outgrowth.", TWENTY-SIXTH MEETING OF THE AMERICAN SOCIETY FOR NEUROCHEMISTRY, SANTA MONICA, CALIFORNIA, USA, MARCH 5-9, 1995. JOURNAL OF NEUROCHEMISTRY 64 (SUPPL. 1). 1995. S41, XP002016510 [X] 1,2,5-10,13-30 * the whole document *
 [DX]   MCKERRACHER, L. ET AL: "Identification of myelin - associated glycoprotein as a major myelin-derived inhibitor of neurite growth", NEURON (1994), 13(4), 805-11, 1994, XP000605260 [DX] 1,2,5-10,13-30 * the whole document *

DOI:   http://dx.doi.org/10.1016/0896-6273(94)90247-X
 [DX]   MUKHOPADHYAY, GITALI ET AL: "A novel role for myelin - associated glycoprotein as an inhibitor of axonal regeneration", NEURON (1994), 13(3), 757-67, 1994, XP000605261 [DX] 1,2,5-10,13-30 * the whole document *

DOI:   http://dx.doi.org/10.1016/0896-6273(94)90042-6
 [DX]   DOHERTY, PATRICK ET AL: "A soluble chimeric form of the L1 glycoprotein stimulates neurite outgrowth", NEURON (1995), 14(1), 57-66, 1995, XP000605271 [DX] 1,2,5-10,13-30 * the whole document *

DOI:   http://dx.doi.org/10.1016/0896-6273(95)90240-6
 [PX]   FILBIN M T ET AL: "The effect of myelin - associated glycoprotein on neurite outgrowth is dependent on the interaction with a neuronal sialo-glycoprotein.", INTERNATIONAL SYMPOSIA ON MYELIN AND MYELIN-FORMING CELLS, OKAZAKI, JAPAN, JULY 8-10, 1995. DEVELOPMENTAL NEUROSCIENCE 17 (3). 1995. 183, XP000605479 [PX] 1-30 * the whole document *
 [PX]   DEBELLARD M-E ET AL: "Myelin - associated glycoprotein inhibits axonal regeneration from a variety of neurons via interaction with a sialoglycoprotein.", MOLECULAR AND CELLULAR NEUROSCIENCE 7 (2). 1996. 89-101, XP000608101 [PX] 1-30 * the whole document *

DOI:   http://dx.doi.org/10.1006/mcne.1996.0007
 [PX]   FILBIN M T: "Myelin - associated glycoprotein: A role in myelination and in the inhibition of axonal regeneration ?.", CURRENT OPINION IN NEUROBIOLOGY 5 (5). 1995. 588-595, XP000608264 [PX] 1-30 * the whole document *

DOI:   http://dx.doi.org/10.1016/0959-4388(95)80063-8
 [PX]   MATSUDA Y ET AL: "Soluble myelin - associated glycoprotein- immunoglobulin G1 chimera protein promotes neurite outgrowth from mouse cerebellar neurons.", NEUROSCIENCE LETTERS 205 (2). 1996. 87-90, XP000605913 [PX] 1,2,5-10,13-30 * the whole document *

DOI:   http://dx.doi.org/10.1016/0304-3940(96)12381-8
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.